Correlation Between Vaccinex and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Vaccinex and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Salarius Pharmaceuticals.
Diversification Opportunities for Vaccinex and Salarius Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vaccinex and Salarius is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Vaccinex i.e., Vaccinex and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vaccinex and Salarius Pharmaceuticals
If you would invest 152.00 in Salarius Pharmaceuticals on December 30, 2024 and sell it today you would lose (66.00) from holding Salarius Pharmaceuticals or give up 43.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Vaccinex vs. Salarius Pharmaceuticals
Performance |
Timeline |
Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Salarius Pharmaceuticals |
Vaccinex and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Salarius Pharmaceuticals
The main advantage of trading using opposite Vaccinex and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |